Literature DB >> 9330247

Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin.

T Oyama1, N Kohno, A Yokoyama, Y Hirasawa, K Hiwada, H Oyama, Y Okuda, K Takasugi.   

Abstract

In rheumatoid arthritis (RA), interstitial-pneumonitis is one of the major extraarticular complications that worsens a patient's prognosis. KL-6, a human MUC1 mucin, has been reported to be a sensitive serum marker for activity of interstitial pneumonitis. We investigated the clinical significance of serum KL-6 level in patients with RA. Serum levels of KL-6 and RA-associated inflammatory markers were evaluated in 177 RA patients. The diagnosis of active interstitial pneumonitis was made by clinical symptoms, pulmonary function tests, chest X-ray film, and high resolution CT. Serum KL-6 was increased in 8 of 9 (88.9%) RA patients with active interstitial pneumonitis but in only 1 of 168 (0.6%) RA patients without active interstitial pneumonitis. No significant correlation was found between KL-6 level and conventional clinical parameters. In RA, abnormal elevation of serum KL-6 strongly indicates the complication of active interstitial pneumonitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9330247     DOI: 10.1007/pl00007584

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  12 in total

1.  Serum KL-6 levels in lung cancer patients with or without interstitial lung disease.

Authors:  Kunihiko Miyazaki; Koichi Kurishima; Katsunori Kagohashi; Mio Kawaguchi; Hiroichi Ishikawa; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 2.  Comprehensive review of current diagnostic and treatment approaches to interstitial lung disease associated with rheumatoid arthritis.

Authors:  Cemal Bes
Journal:  Eur J Rheumatol       Date:  2018-07-01

3.  Interstitial lung disease in rheumatoid arthritis.

Authors:  Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

4.  Relationship between matrix metalloproteinase-3 serum level and pulmonary artery systolic pressure in patients with rheumatoid arthritis.

Authors:  Tetsuro Sugiura; Mikio Kamioka; Shigeo Yamanaka; Taisuke Hisahara; Yoko Hirakawa; Yoshihisa Matsumura
Journal:  Heart Vessels       Date:  2017-08-21       Impact factor: 2.037

5.  KL-6 as a Biomarker of Interstitial Lung Disease Development in Patients with Sjögren Syndrome: A Retrospective Case-Control Study.

Authors:  Yu-Hsiang Chiu; Chen-Chih Chu; Chun-Chi Lu; Feng-Cheng Liu; Shin-En Tang; Shi-Jye Chu; San-Yuan Kuo; Hsiang-Cheng Chen
Journal:  J Inflamm Res       Date:  2022-04-08

6.  Increase of KL-6 in sera of uveitis patients with sarcoidosis.

Authors:  Nobuyoshi Kitaichi; Satoshi Kotake; Hitoshi Shibuya; Yukiho Yamada; Hitoshi Chiba; Kenichi Namba; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-11       Impact factor: 3.117

7.  Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis.

Authors:  Gerd R Burmester; Michael E Weinblatt; Iain B McInnes; Duncan Porter; Olga Barbarash; Mykola Vatutin; Istvan Szombati; Ehsanollah Esfandiari; Matthew A Sleeman; Christopher D Kane; Guy Cavet; Bing Wang; Alex Godwood; Fabio Magrini
Journal:  Ann Rheum Dis       Date:  2012-12-12       Impact factor: 19.103

8.  KL-6 concentration in pulmonary epithelial lining fluid is a useful prognostic indicator in patients with acute respiratory distress syndrome.

Authors:  Tomohiro Kondo; Noboru Hattori; Nobuhisa Ishikawa; Hiroshi Murai; Yoshinori Haruta; Nobuyuki Hirohashi; Koichi Tanigawa; Nobuoki Kohno
Journal:  Respir Res       Date:  2011-03-22

Review 9.  The multifaceted aspects of interstitial lung disease in rheumatoid arthritis.

Authors:  Lorenzo Cavagna; Sara Monti; Vittorio Grosso; Nicola Boffini; Eva Scorletti; Gloria Crepaldi; Roberto Caporali
Journal:  Biomed Res Int       Date:  2013-09-25       Impact factor: 3.411

Review 10.  Up-to-Date Information on Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Authors:  Takafumi Suda
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2016-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.